EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Discovery of novel 1,3,4-thiadiazole derivatives as potential dual EGFR/VEGFR inhibitors with activity against breast, colon, and liver cancer cells: biological evaluation and molecular docking investigation

Amany Belal, Mohammed A S Abourehab, Reem I Alsantali, Ahmad J Obaidullah iD, Randa Erfan, Yasmine Elwan, Ahmed A Gaber iD, Ahmed B M Mehany, Rehab Sabour, Walid E Elgammal iD

RSC Advances · 2026

DOI: 10.1039/d6ra07414f ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Amany Belal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University P. O. Box 11099 Taif 21944 Saudi Arabia. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Umm Al-Qura University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New derivatives of the 1,3,4-thiadiazole-quinazoline-4(3 H )-one scaffold were synthesized and evaluated for their cytotoxic effects on breast (MCF-7), hepatic (HepG-2), and colorectal (HCT-116) carcinomas.

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University P. O. Box 11099 Taif 21944 Saudi Arabia.
  • Pharmaceutical Sciences Department, College of Pharmacy, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P. O. Box 2457 Riyadh 11451 Saudi Arabia.
  • Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University Cairo Egypt.
  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt.
  • Zoology Department, Faculty of Science (Boys), Al-Azhar University Nasr City 11884 Cairo Egypt.

ORCID-Profile: Ahmad J Obaidullah, Ahmed A Gaber, Walid E Elgammal

Förderung

  • Umm Al-Qura University

Zitieren

APA

Belal, A., Abourehab, M. A. S., Alsantali, R. I., Obaidullah, A. J., Erfan, R., Elwan, Y., Gaber, A. A., Mehany, A. B. M., Sabour, R., & Elgammal, W. E. (2026). Discovery of novel 1,3,4-thiadiazole derivatives as potential dual EGFR/VEGFR inhibitors with activity against breast, colon, and liver cancer cells: biological evaluation and molecular docking investigation. RSC Advances. https://doi.org/10.1039/d6ra07414f

Vancouver

Belal A, Abourehab MAS, Alsantali RI, Obaidullah AJ, Erfan R, Elwan Y, et al. Discovery of novel 1,3,4-thiadiazole derivatives as potential dual EGFR/VEGFR inhibitors with activity against breast, colon, and liver cancer cells: biological evaluation and molecular docking investigation. RSC Advances. 2026. doi:10.1039/d6ra07414f

BibTeX
@article{Belal2026,
  author = {Belal, Amany and Abourehab, Mohammed A S and Alsantali, Reem I and Obaidullah, Ahmad J and Erfan, Randa and Elwan, Yasmine and Gaber, Ahmed A and Mehany, Ahmed B M and Sabour, Rehab and Elgammal, Walid E},
  title = {Discovery of novel 1,3,4-thiadiazole derivatives as potential dual EGFR/VEGFR inhibitors with activity against breast, colon, and liver cancer cells: biological evaluation and molecular docking investigation},
  journal = {RSC Advances},
  year = {2026},
  doi = {10.1039/d6ra07414f}
}
Kostenlos starten →